University of Gothenburg
  2. About
  3. Find staff
  4. Magdalena Claeson

Magdalena Claeson

Affiliated to Research

Department of Dermatology and Venereology
Mail
magdalena.claeson@gu.se
Visiting address
Gröna stråket 16 Pl 2 SU/Sahlgrensk
41345 Göteborg
Postal address
Sahlgrenska Universitetssjukhuset
41345 Göteborg

About Magdalena Claeson

I am a consultant dermatologist and a postdoctoral researcher with a PhD in Medical Science.

Between 2013 and 2017, I served as a course coordinator for the Dermatology course during the Programme in Medicine at the University of Gothenburg.

Research focus area

My area of expertise is within skin cancer epidemiology. For example, I have published data from a prospective cohort study with 40,000 participants where we identified risk factors fo the common skin cancer keratoacanthoma: older age, male sex, fair skin type, inability to tan, smoking and alcohol (Claeson et al. JAMA Dermatol. 2020).

My primary research interest is in melanoma of the skin, where I have published a study on the alarming increase in melanoma incidence in Western Sweden during the past decades (Claeson et al. Melanoma Res. 2012). Further, we have studied thin (≤ 1 mm thickness) melanoma and have shown that thin tumours constitute the majority of melanomas diagnosed in Western Sweden (55%) (Claeson et al. Acta Derm Venereol 2017), resulting in high health care costs and suffering from the patients. People diagnosed with a thin melanoma generally have high survival rates. However, thin tumours still cause a substantial proportion of deaths due to the volume of disease. That is why I have focused my research also on identifying prognostic factors for thin melanoma. In a population-based registry study from Queensland, Australia, we found that tumours located on the scalp have 6 times higher risk of death (Claeson et al. Br J Dermatol 2020). Since 2020, I am an invited member of the Swedish Melanoma Study Group (SMSG).

International postdoc

From 2018 until 2020, I was working as a postdoctoral fellow in skin cancer epidemiology and experimental dermatology at the Queensland Institute of Medical Research (QIMR) Berghofer and at the University of Queensland in Brisbane, Australien.

My research in the media

Read more about my research on keratoacanthoma in a press release from QIMR Berghofer: Study finds ways to reduce the risk of common Queensland skin tumour.